Parkman Healthcare Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $4.8M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $8.65M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $2.84M | Sell |
|
|||||
|
2021
Q4 | $9.76M | Buy |
|
|||||
|
2021
Q3 | $10.3M | Sell |
|
|||||
|
2021
Q2 | $19.3M | Buy |
|
|||||
|
2021
Q1 | $14.5M | Buy |
|
|||||
|
2020
Q4 | $9.91M | Sell |
|
|||||
|
2020
Q3 | $9.06M | Buy |
|
|||||
|
2020
Q2 | $6.97M | Buy |
|